HCS Pharma 

HCS Pharma is a biotechnology company that develops and manufactures a groundbreaking 3D technology, BIOMIMESYS.

OWNER

Nathalie MAUBON (See Profile)


Sector

Biotech

Stage

Development, market readiness, clinical trial

Country

France


BIOMIMESYS is a patented 3D technology that faithfully recreates human organ microenvironment.

BIOMIMESYS is the only 3D ready-to-use technology usable on robotic platforms.

BIOMIMESYS is the only hydroscaffold on the market that faithfully recreates Extra-Cellular Matrix.

4 products already developed and marketed: for liver, for brain, for adipose tissu and for cancerous cells.

Status

Approved

IP Type

Patent

Time

15 years

Countries

Belgium
Denmark
Finland
France
Germany
Italy
Netherlands
Spain
Switzerland
United Kingdom

Coverage

Process how to create hydroscaffold from HA-based hydrogel to create BIOMIMESYS.

Know more of this patent

View more

Status

Pending

IP Type

PCT

Time

–

Countries

Coverage

This information is confidential, do not share or copy.

You can visit their website or

Download the Pitch Deck

Under evaluation at least till: November 24th

If you want to have more information or you want to review the project, you have to login or register

KEEP REVIEWING

©2023 BioExpert Network

About cookies

This website uses cookies to give you the best user experience. If you continue browsing you are giving your consent for the acceptance of those cookies and the acceptance of our cookies policy.

If you continue to browse and use this website you are agreeing to comply with and be bound by the following Terms of Use

ACEPTAR
Aviso de cookies

Log in with your credentials

or    

Forgot your details?

Create Account

Skip to toolbar